Attending the health.tech conference Tech Conference in Munich last week was an enlightening experience for us at TTE Strategy. The event provided a thorough exploration of the industry's evolving landscape and presented valuable case studies illustrating how leading organizations are tackling challenges such as regulatory barriers, outdated processes, and underutilized data. At TTE Strategy, we believe that overcoming these hurdles requires setting a clear strategic direction and developing a well-thought-out transformation pathway. Our participation in this conference strengthens our resolve to truly understand our clients' needs and actively engage in the ongoing industry discussions to transform the medical sector. Philippe Bourbon Catharina Rech Jana Lossau Vedika Dabriwal Claudia Manriquez Diana Alborch Escobar Nico V. #HealthTech #Pharma #MedTech #ClientCentricSolutions
TTE Strategy’s Post
More Relevant Posts
-
📢 Discover the impact of patient and public involvement in research and co-design of health technology innovations. 📺 In this presentation, Alison Keogh takes a deep dive into the distinction between #Participation - Where people take part in a research study, #Engagement - Where information, knowledge, and results about research are shared and disseminated, and #Involvement - Where patients and the public are actively involved in research projects and organisations as consultants and collaborators. Learn how these dynamic approaches are shaping the future of healthcare and research in the Mobilise-D project 👇 https://lnkd.in/dZAHVztf #PatientEngagement #PPIE Innovative Health Initiative (IHI) EFPIA - European Federation of Pharmaceutical Industries and Associations DARE Foundation - Digital Lifelong Prevention MobilNOR
How to involve patients and the public in research and innovation | Alison Keogh
https://www.youtube.com/
To view or add a comment, sign in
-
Our CEO, Hakim Yadi Ph.D. OBE shared his insights in part 2 of the Scrip series “Scrip Asks… What does 2024 hold for biopharma?” on the funding environment, M&A, and partnering. In this latest feature, Hakim stresses the importance of breaking away from siloed solutions, advocating for comprehensive, system-wide approaches to meet healthcare demands. He added: “Considering the inherent global market instability, the ever-evolving landscape of medical technologies, and the surging market demands, sticking to the status quo is a surefire way to fall behind. To not only survive but thrive in 2024, businesses must embrace agility, strategy, and assertiveness. This necessitates a fundamental overhaul of outdated business models and a willingness to seek external investments that can modernize global health care to align with the shifting global needs, interests, and capabilities.” Read the full article here: bit.ly/3Um4Ri3 #Biopharma #Healthcare #Innovation #TechBio #Scrip #Funding
To view or add a comment, sign in
-
Clinical Trials Day is today! As we celebrate, it's important to consider both the achievements and the challenges that come with developing new therapies. In Gadi Saarony’s recent article for @ Forbes Technology Council, he called on our industry to take a pragmatic approach to adopting new technologies in clinical research, ensuring they truly benefit the process and, most importantly, the patients waiting for life-changing treatments. #ClinicalTrialsDay #CTD2024 #ClinicalResearch #ClinicalTrials
To view or add a comment, sign in
-
A highlight of the IQVIA Innovation Day agenda includes Murray Aitken and other industry leaders discussing the latest research on the impact of technology on clinical trials and possible solutions. Learn more about the event agenda and register here: https://bit.ly/4cnAoGL #ClinicalTechnology #ClinicalTrials #IQVIAInnovationDay
Meet IQVIA at Innovation Day 2024!
To view or add a comment, sign in
-
Clinical Safety Officer and Care Quality Commission Lead at 8foldGovernance | U7s #RFU Rugby Coach | Assistant Cub Scout Leader
This new service looks like a well intended repository to me with some good graphics and flow diagrams to simplify existing regulations and guidance. However…… There is still a long way to go in harmonising NHS standards and compliance between International Standards (ISO 14971 & ISO 27001) to make the transition easier for medical device manufacturers. Where possible, when we support clients at 8foldGovernance we try to harmonise documentation to prevent duplication and territorial silos of policies and procedures. In addition, I am not sure if the service sign posts developers to the risks of crossing into a stand alone regulatory activity - which the CQC discuss in their own regulated activity guidance. I have discussed this is a blog previously published - https://lnkd.in/dbKvEzXa Hopefully this is just the start of a very useful resource! #jointhe8fold
📰 The Innovative Devices Access Pathway (IDAP) is a great example of what happens when #regulators and #innovators come together to bring technology to market. Full article from Digital Health in the first comment. Our mission has always been to support the adoption of ethical innovation in healthcare and its great to see NICE - National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency collaborating to join the dots between: 💡 Innovation 📜 Regulation 📚 Evidence 🏥 Impact at Scale Congratulations to the first cohort! 👏 HistoSonics, Inc. Roche Diagnostics UK & Ireland Upfront Diagnostics Lenus Health EarSwitch Avegen 52North - creators of Neutrocheck® Presymptom Health
To view or add a comment, sign in
-
MD #PrecisionMedicine 精密医学 thought & technology leader, Keynote Speaker, industry advisor 30K Followers #Biotech #Diagnostics #DrugDiscovery #Innovation #StartUps #ArticialIntelligence #Investing
I am honored to join the team of ECTT to foster innovation in medicine & healthcare, in particular re Precision Medicine & Precision Health by connecting EU technology with Chinese resources ranging from investments to support for scale in one of largest healtcare markets. https://www.ectt.eu/ #innovation #medicine #healthcare #healthtech #digitalhealth #precisionmedicine #precisionhealth #prevention #drugdiscovery #drugdevelopment #bigdata #artificialintelligence #multiomics #clinicalresearch #clinicaltrial #clinicaldevelopment #ctm #china #europe #technology #technologytransfer #collaboration #investing #venturecapital BioM Biotech Cluster Development GmbH Wirtschaftsbeirat Bayern Junger Wirtschaftsbeirat Bayern
To view or add a comment, sign in
-
Embracing the Future of Clinical Trials with Interactive Response Technology (IRT). #InteractiveResponseTechnology (IRT) has revolutionized the way clinical trials are conducted, providing unmatched benefits in patient randomization, drug supply management, and data collection. As technology advances, IRT will further enhance the efficiency and reliability of clinical trials. In this fast-evolving landscape, learn more about IRT by exploring our blog post using the link: https://lnkd.in/dPMGrqjq #ClinicalTrials #IRT #HealthTech #Innovation #ClinicalResearch #XceneResearch
To view or add a comment, sign in
-
As per the Tufts Impact Report, a substantial 70% of investigative site staff have observed an increasing difficulty in conducting clinical trials over the past five years. In this Medable, Inc webinar, listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of #eCOA, its benefits, and ways to improve the technology: https://lnkd.in/eTbqukbG #clinicalresearch #clinicaltechnology
To view or add a comment, sign in
-
What are the current market conditions and challenges faced by medtech companies? Gain key insights from Diana Saraceni and Alessio Beverina from Panakes Partners now on the first episode of Emerging Medtech Today hosted by Henry Peck and powered by LSI - Life Science Intelligence™ . Tune in at emergingmedtechtoday.com and join the conversation! #MedtechLeaders #LSI #Medtech #HealthTech #DigitalHealth #FutureOfHealth
To view or add a comment, sign in
-
At the SCRS West: Clinical Tech & Innovation Summit, nearly 300 industry leaders gathered to explore opportunities for addressing clinical technology congestion. Throughout the Summit's sessions and discussions, several recurring themes emerged, emphasizing the crucial role of sites, sponsors, CROs, and service providers in shaping the evolution of clinical trial technology development. Read highlights from the Summit and action-items to power your technology implementation ⇢ https://bit.ly/3R60aHg
To view or add a comment, sign in
6,686 followers
We're glad you had an enlightening experience. It was great having you here!